Pathway Medical Adds $1.5 To Series D
Posted on: May 21, 2009 by PEHub AdministratorNo Comments »
Pathway Medical Technologies, a developer of endovascular treatments for peripheral arterial disease received a $1.5 million investment from Washington Research Foundation, independent, nonprofit foundation, as part of the company’s Series D financing. The round totals $42.5 million with investments from Forbion Capital Partners, Giza Venture Capital, HLM Venture Partners, Latterell Venture Partners, and Oxford Bioscience [...]
